Increased risk of papillary thyroid cancer related to hormonal factors in women

Tumor Biology

Volumn 36, Issue 7, 2015, Pages 5127-5132

  Wang, Ping ^a   Lv, Long ^a   Qi, Feng ^b   Qiu, Feng ^a  

^a Gaochun People's Hospital   (China)

^b Maternal and Child Health Care Hospital of Weifang   (China)

Author keywords

Menstrual factors; Meta analysis; Papillary thyroid cancer; Reproductive factors

Indexed keywords

ARTICLE; BREAST FEEDING; CANCER RISK; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENARCHE; MENOPAUSE; MENSTRUATION; ORAL CONTRACEPTIVE USE; PARITY; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; SYSTEMATIC REVIEW; THYROID PAPILLARY CARCINOMA; AGE; CARCINOMA; CARCINOMA, PAPILLARY; MALE; META ANALYSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; THYROID NEOPLASMS;

HORMONE;

AGE FACTORS; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; HORMONES; HUMANS; MALE; MENARCHE; MENOPAUSE; PREGNANCY; REPRODUCTION; RISK FACTORS; THYROID NEOPLASMS;

EID: 84938216505     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3165-0     Document Type: Article

References (28)

1. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 2009;20:75–86.
2. Choi WJ, Kim J. Dietary factors and the risk of thyroid cancer: a review. Clin Nutr Res. 2014;3:75–88.
3. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 2012;7:e29177.
4. Spitz MR, Sider JG, Katz RL, Pollack ES, Newell GR. Ethnic patterns of thyroid cancer incidence in the United States, 1973–1981. Int J Cancer. 1988;42:549–53.
5. Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E, et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Sante Publique. 1990;38:27–34.
6. Zamora-Ros R, Rinaldi S, Biessy C, Tjonneland A, Halkjaer J, Fournier A, et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study. Int J Cancer. 2014.
7. Braganza MZ, de Gonzalez AB, Schonfeld SJ, Wentzensen N, Brenner AV, Kitahara CM. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev Res (Phila). 2014;7:418–25.
8. Kabat GC, Kim MY, Wactawski-Wende J, Lane D, Wassertheil-Smoller S, Rohan TE. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control. 2012;23:2031–40.
9. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:1751–9.
10. Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer. 2005;116:433–8.
11. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol. 2000;151:765–72.
12. Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR. Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States). Cancer Causes Control. 1998;9:341–9.
13. Akslen LA, Nilssen S, Kvale G. Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br J Cancer. 1992;65:772–4.
14. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2002;11:51–7.
15. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
20. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 470–461.
21. Tahboub R, Arafah BM. Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23:769–80.
22. Zane M, Catalano V, Scavo E, Bonanno M, Pelizzo MR, Todaro M, et al. Estrogens and stem cells in thyroid cancer. Front Endocrinol (Lausanne). 2014;5:124.
23. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets. 2008;8:367–77.
24. Chaudhuri PK, Prinz R. Estrogen receptor in normal and neoplastic human thyroid tissue. Am J Otolaryngol. 1989;10:322–6.
25. Islami F, Cao Y, Kamangar F, Nasrollahzadeh D, Marjani HA, Shakeri R, et al. Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case–control study in a high-risk area and literature review. Eur J Cancer Prev. 2013;22:461–6.
26. Schonfeld SJ, Neta G, Sturgis EM, Pfeiffer RM, Hutchinson AA, Xu L, et al. Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid. 2012;22:151–6.
27. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012;44:319–22.
28. Brenner AV, Neta G, Sturgis EM, Pfeiffer RM, Hutchinson A, Yeager M, et al. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer. PLoS One. 2013;8:e57243.